Cited by 760Osteoarthritis Treatment and MechanismsTissue Engineering and Regenerative MedicineBone Tissue Engineering Materials

Engineering cartilage tissue

Open access
Chung, Cindy, Burdick, Jason A.·2008·Advanced Drug Delivery Reviews

Abstract

Cartilage tissue engineering is emerging as a technique for the regeneration of cartilage tissue damaged due to disease or trauma. Since cartilage lacks regenerative capabilities, it is essential to develop approaches that deliver the appropriate cells, biomaterials, and signaling factors to the defect site. The objective of this review is to discuss the approaches that have been taken in this area, with an emphasis on various cell sources, including chondrocytes, fibroblasts, and stem cells. Additionally, biomaterials and their interaction with cells and the importance of signaling factors on cellular behavior and cartilage formation will be addressed. Ultimately, the goal of investigators working on cartilage regeneration is to develop a system that promotes the production of cartilage tissue that mimics native tissue properties, accelerates restoration of tissue function, and is clinically translatable. Although this is an ambitious goal, significant progress and important advances have been made in recent years.

Integrity signals

Registry

Crossref · 10.1016/j.addr.2007.08.027

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chung, C., & Burdick, J. A.
Affiliations
University of Pennsylvania (US)
Corresponding author
Burdick, Jason A.
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2008-01
Volume
60
Issue
2
Pages
243-262
ISSN
0169-409X (ISSN-L)
OpenAlex
W1987032519
Cited by
760
References
3
Citations by year
2026: 9 · 2025: 29 · 2024: 29 · 2023: 31 · 2022: 37 · 2021: 37 · 2020: 27 · 2019: 39 · 2018: 40 · 2017: 47 · 2016: 54 · 2015: 52 · 2014: 64 · 2013: 61 · 2012: 52
FWCI
4.10
Type
journal article
Language
en
Open access
Locations
  • Advanced Drug Delivery Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Science Foundation
  • National Institute of Dental and Craniofacial Research (K22DE015761)
Topics
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › Bone Tissue Engineering Materials
Keywords
cartilage tissue engineering, cartilage regeneration, chondrocytes, fibroblasts, stem cells, biomaterials, cartilage defects, cell delivery
MeSH terms
Animals, Cartilage, Cell Differentiation, Fibroblasts, Humans, Stem Cells, Chondrocytes, Tissue Engineering, Intercellular Signaling Peptides and Proteins, Tissue Scaffolds

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review